ProKidney Corp. (PROK)
Last updated: 2026-11-13 09:24:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
ProKidney Corp. (PROK) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.15, with a market capitalization of $236.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.87 to $2.66. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$236.14M | |
$1.12 | |
$1.18 | |
$1.09 | |
$1.13 | |
1.03M | |
1.42M | |
-- | |
$2.66 | |
$0.87 | |
-- | |
-- |
ProKidney Corp. (PROK) Pre-Market Stock Price
ProKidney Corp. (PROK) is trading at $1.14 in pre-market trading as of 2026-11-13 00:50:00, up 0.62% ($0.01) from the previous close of $1.13
Pre-market trading shows how investors are pricing PROK before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
ProKidney Corp. (PROK) 7-Day Stock Price Change
Over the past seven days, ProKidney Corp. (PROK) moved from $1.12 to $1.15, representing a gain of 2.23% ($0.02).
The stock traded between $1.00 and $1.27 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.03 million shares, down versus the previous seven-day period, indicating lower trading activity.
PROK 52-Week Price Position
Position in Range: 15.4%
PROK is currently trading at $1.15, placing it 15.4% of the way from its 52-week low of $0.87 to its 52-week high of $2.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is ProKidney Corp. (PROK)?
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
ProKidney Corp. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 231 |
| Exchange | NASDAQ |
| Company Website |
PROK Stock Events
View the latest dividend and stock split events for ProKidney Corp.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
PROK News
Latest news related to ProKidney Corp. and PROK stock.
- Read Full Article
- Read Full Article
ProKidney Q3 EPS $(0.17) Misses $(0.14) Estimate, Sales $174.000K Beat $124.600K Estimate
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 41.67 percent decrease over losses of $(0.12) per share from the
Ways to Trade PROK at MEXC
How to Buy ProKidney Corp. (PROK) Stock on MEXC
Eligible investors can buy real shares of ProKidney Corp. (PROK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is ProKidney Corp. (PROK) stock price today?
2.Is PROK stock going up or down today?
3.What is PROK pre-market price?
4.What is PROK after-hours price?
5.Is PROK stock trading now?
6.Where does PROK sit relative to its 52-week high and low?
7.What sector is ProKidney Corp. in?
8.What is ProKidney Corp.'s market capitalization and where is it listed?
9.How is PROK valued in terms of P/E ratio and EPS?
10.Does ProKidney Corp. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PROK, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
PROK Stock Calculator
Estimate the value between PROK shares and USD.
PROK Shares to USD
1.00 PROK shares = 1.145 USD
Calculations are estimates based on the latest available price and are for reference only.



